Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus fluvoxamine for separation anxiety disorder with school refusal in children
IRCT20211004052670N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketamine and fluvoxamine in separation anxiety disorder (SAD) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Anxiety score, Age and 3 more. Started Nov 2021; status: completed.
02
Drugs
ketaminefluvoxamine
03
Conditions
separation anxiety disorder (SAD)
Beyond the preview
Go deeper on IRCT20211004052670N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211004052670N3.